Newsroom

News

The Leibniz Institute for New Materials (INM), Saarland University (UdS) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are launching the Leibniz Science Campus “Living Therapeutic Materials” on 1 July 2020. In a competitive process, the Leibniz Association approved a grant of 900,000 € for joint research into new materials for the personalised administration of biotherapeutics, based at the Saarland campus. In addition to the funding from the Leibniz Association, the INM, the HIPS and the UdS are also contributing around three million euros to the project from their own funds. Furthermore, the State Chancellery is also contributing an additional 400,000 €.

29.06.2020

HIPS

News

Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre for Infection Research (HZI) on the campus of the Saarland University.

25.06.2020

HIPS

News

Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.

17.06.2020

HZI Campus

Mikroskopische Aufnahme einer Lungengewebsprobe mit einer aktiven Zytomegalie-Infektion. Charakteristisch sind vergrößerte Lungenzellen mit Einschluss im Zellkern.

News

Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.

10.06.2020

HZI Campus

News

09.06.2020

HZI Campus

Meningokokken (orange) haben sich an menschliche Wirtszellen (grün) angeheftet. Rasterelektronenmikroskopische Aufnahme in Falschfarbendarstellung.

News

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250 bacterial genes. ProQ ensures that meningococci can better repair their DNA if damaged and it makes them resistant to oxidative stress. Both these factors contribute significantly to the bacteria's pathogenic properties. This was reported by research groups led by the Würzburg scientists Christoph Schoen from the Julius-Maximilians-Universität (JMU) and Jörg Vogel from the Helmholtz Institute for RNA-based Infection Research (HIRI) in the journal Nature Communications. The HIRI is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the JMU.

04.06.2020

HIRI

Back to the first page
...
59
60
61
62
...
147

HZI in the media

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025

Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025

World Today News

Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

19.09.2025

Verband Deutscher Biologen e.V.

purposes.

Researchers at the HIRI, a site of the Braunschweig Helmholtz Center for Infection Research (HZI), in cooperation with the Julius

19.09.2025

NewsBreak

... ihr Team vom Helmholtz-Institut für One Health (HIOH) in Greifswald – einem Standort des Helmholtz-Zentrums ...

18.09.2025

Management & Krankenhaus

... der TU Braunschweig, dem Braunschweig Integrated Centre of Systems Biology (BRICS) und dem Helmholtz-Zentrum für ...

15.09.2025

DeutschesGesundheitsPortal

Das Institut ist ein Teil des rennommierten Helmholtz-Zentrums für Infektionsforschung ...

11.09.2025

NDR Norddeutscher Rundfunk

... gearbeitet werden soll. Greifswald (dpa/mv) - In einem eigenen Gebäude sollen Forscher des Helmholtz-Instituts ...

11.09.2025

n-tv

Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einem Standort des Braunschweiger Helmholtz- ...

11.09.2025

MTA Dialog

Studie und Hersteller des Prüfpräparats. Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) war bei ...

11.09.2025

Kölner News Journal

at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute of Molecular Infection Biology (IMIB) in Würzburg has

10.09.2025

Phys.org

Leiter der Abteilung Chemische Biologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig www.helmholtz-hzi.de ...

10.09.2025

BR Bayerischer Rundfunk

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.